title: [Cyclic neutropenia. Detection of a mutation in the gene for neutrophil elastase (ELA2)].
abstract: OBJECTIVE
  Cyclic neutropenia is a rare congenital hematopoietic disease which occurs sporadically or as an autosomal dominantly inherited disorder. Recently, the locus for cyclic neutropenia was mapped to chromosome 19p13.3. Autosomal dominant and sporadic cyclic neutropenia are now attributable to mutations of the ELA2 gene encoding neutrophil elastase.
  
  
  METHODS
  Based on a case report we review the clinical picture and diagnostic criteria of cyclic neutropenia and report about the recent molecular biological findings and current treatment options.
  
  
  RESULTS
  Serial blood cell counts revealed the characteristic oscillations of the circulating neutrophils with 21-day periodicity from near normal to extremely low levels. The neutrophil nadir lasted 3-5 days. The neutropenia was associated with fever, malaise, painful oral aphthous ulcers and lymphadenopathy. Mutational analysis of the patient's genomic DNA revealed a single base-pair transition (nt 4716, G-->A) in intron 4 of ELA2. Since the initiation of therapy with subcutaneous recombinant human granulocyte-stimulating colony factor (rHuG-CSF) 24 months ago, the patient has been free of symptoms.
  
  
  CONCLUSIONS
  Despite the typical medical history with onset of the symptoms in early infancy the diagnosis of cyclic neutropenia was not established until the age of 9 years. A common reason for the delayed diagnosis of cyclic neutropenia may be unawareness of the rare but distinctive disorder and the practice of obtaining screening blood counts without leukocyte differentials. Patients with cyclic neutropenia should be enrolled to the Severe Chronic Neutropenia International Registry (SCNIR).
authors.affiliation: Klinik und Poliklinik für Hautkrankheiten, Universitätsklinikum Münster, Von Esmarchstrasse 58, 48149 Münster. schillm@uni-muenster.de
authors.forename: M
authors.initials: M
authors.lastname: Schiller
authors.forename: M
authors.initials: M
authors.lastname: Böhm
authors.forename: C
authors.initials: C
authors.lastname: Zeidler
authors.forename: M
authors.initials: M
authors.lastname: Germeshausen
authors.forename: K
authors.initials: K
authors.lastname: Welte
authors.forename: T A
authors.initials: TA
authors.lastname: Luger
authors.forename: G
authors.initials: G
authors.lastname: Bonsmann
mesh_terms: D020029:Base Pairing / Q000235:genetics; D002648:Child; D002869:Chromosome Aberrations; D004252:DNA Mutational Analysis; D005260:Female; D000069585:Filgrastim; D005799:Genes, Dominant / Q000235:genetics*; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D006801:Humans; D007279:Injections, Subcutaneous; D007438:Introns; D007958:Leukocyte Count; D019272:Leukocyte Elastase / Q000235:genetics*; D009503:Neutropenia / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology; D009504:Neutrophils / Q000276:immunology; D017354:Point Mutation / Q000235:genetics*; D011994:Recombinant Proteins; D013281:Stomatitis, Aphthous / Q000188:drug therapy / Q000235:genetics / Q000276:immunology
chemical_list: D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D019272:Leukocyte Elastase; D000069585:Filgrastim